Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Orgovyx

(or-GOH-vix)
A drug used to treat adults with advanced prostate cancer. Orgovyx binds to gonadotropin-releasing hormone (GnRH) receptors in the pituitary gland, which blocks the pituitary gland from making the hormones follicle-stimulating hormone (FSH) and luteinizing hormone (LH). This causes the testicles to stop making testosterone. Orgovyx may stop the growth of cancer cells that need testosterone to grow. It is a type of GnRH antagonist. Also called relugolix.
More Information
Search NCI's Dictionary of Cancer Terms